NTRK1 and cancer: Similarly, inhibiting PI3K or AKT alone resulted in feedback activation of upstream receptor tyrosine kinases [41, 42], highlighting the necessity of simultaneous targeting of multiple key nodes in cancer signaling networks for anticancer therapy to be effective.